Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Cardiovascular risk and lipid management beyond statin therapy: the potential role of omega-3 polyunsaturated fatty acid ethyl esters

Halcox, Julian 2013. Cardiovascular risk and lipid management beyond statin therapy: the potential role of omega-3 polyunsaturated fatty acid ethyl esters. Clinical Lipidology 8 (3) , pp. 329-344. 10.2217/clp.13.16

Full text not available from this repository.

Abstract

Although statins are widely effective at reducing LDL cholesterol (LDL–C) and clinical cardiovascular events, the risk of cardiovascular disease remains high in certain patient subgroups, despite effective LDL–C reduction. This is typically the case in those with Type 2 diabetes. This ‘residual risk’ is partly attributable to lipid abnormalities distinct from LDL–C, such as elevated triglyceride (TG)–rich lipoproteins and low levels of HDL cholesterol (HDL–C). Clinical trials demonstrate that use of other lipid–modifying therapies in combination with statins can further improvelipidprofiles:inhibitorsofcholesterolandbileaciduptakemainlyaffectLDL-C,whileniacin,fibratesand ω–3 polyunsaturated fatty acid ethyl esters target other plasma lipids, particularly TG and HDL–C. In current practice,patientswithhigherTGsandlowerHDL-Cappeartohavethegreatestpotentialtobenefitfromuseof additional medications on the background of statin therapy.

Item Type: Article
Status: Published
Schools: Medicine
Publisher: Future Medicine
ISSN: 1758-4299
Last Modified: 12 Apr 2018 19:50
URI: https://orca.cardiff.ac.uk/id/eprint/110023

Citation Data

Cited 4 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item